Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Artios Pharma closes £25mm Series A round

Executive Summary

Newly launched cancer-focused biotech Artios Pharma Ltd. raised £25mm ($33.2mm) through its Series A round led by SV Life Sciences. Additional investors included Imperial Innovations (which took a 14.9% ownership stake with a £5.1mm investment), Merck Ventures, Arix Bioscience, CRT Pioneer Fund (managed by Sixth Element Capital), and AbbVie Ventures.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

Advertisement
UsernamePublicRestriction

Register